source
- GSK to launch large trial testing shingles vaccine’s potential to reduce Alzheimer’s riskGSK announced it will conduct a large-scale clinical study to evaluate whether the shingles vaccine can lower the risk of developing Alzheimer’s disease. The move follows observations from analyses…
- U.S. drug shortages climb to 227 active cases in Q2 2026The United States reported a rise in active medication shortages during the second quarter of 2026, with the total reaching 227. The increase signals growing pressure on the pharmaceutical supply…